These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 13069905)

  • 1. [Prevention and treatment of nausea and vomiting of motion sickness].
    AUBERTIN E
    J Med Bord; 1953 Apr; 130(4):573-4. PubMed ID: 13069905
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME; Royal JW; Shaw JE; Schmitt LG
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of anti-seasick properties of pyrroxan and dimenhydrinate under conditions of maximal and submaximal statokinetic load in humans].
    Shabanov PD; Anokhin AG
    Eksp Klin Farmakol; 2005; 68(3):50-5. PubMed ID: 16047682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intravenous use of diphenhydramine hydrochloride in the control of nausea and vomiting.
    McCAWLEY EL; KULASAVAGE RJ; WARRINGTON WR; PASQUESI TJ
    Portland Clin Bull; 1951 Dec; 5(3):43-8. PubMed ID: 14891488
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone prevents postoperative nausea and vomiting more effectively in women with motion sickness.
    Lee Y; Lai HY; Lin PC; Huang SJ; Lin YS
    Can J Anaesth; 2003 Mar; 50(3):232-7. PubMed ID: 12620944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroencephalographic studies on a dimenhydrinate in a chewing-gum for motion sickness].
    Reimann HJ; Erbel F
    Ther Ggw; 1981 Sep; 120(9):837-44. PubMed ID: 7292363
    [No Abstract]   [Full Text] [Related]  

  • 9. Dimenhydrinate use for children with vomiting.
    Enarson P; Gouin S; Goldman RD
    Can Fam Physician; 2011 Apr; 57(4):431-2. PubMed ID: 21490354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Motion sickness--where can one turn?].
    Frey OR
    Med Monatsschr Pharm; 2002 Jul; 25(7):244-5. PubMed ID: 12148239
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic effects of granisetron on postoperative nausea and vomiting in patients with and without motion sickness.
    Fujii Y; Toyooka H; Tanaka H
    Can J Anaesth; 1996 Feb; 43(2):110-4. PubMed ID: 8825534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of centrogenous vomiting (seasickness, roentgen intoxication, emesis gravidarum etc)].
    FREUND R
    Medizinische; 1952 Mar; 13():420-2. PubMed ID: 14940589
    [No Abstract]   [Full Text] [Related]  

  • 16. Motion sickness, ginger, and psychophysics.
    Mowrey DB; Clayson DE
    Lancet; 1982 Mar; 1(8273):655-7. PubMed ID: 6121968
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights.
    Golding JF; Paillard AC; Normand H; Besnard S; Denise P
    Aerosp Med Hum Perform; 2017 Jan; 88(1):3-9. PubMed ID: 28061915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparison of vitamin B6 and dimenhydrinate in the treatment of nausea and vomiting in early pregnancy.
    Babaei AH; Foghaha MH
    Iran J Nurs Midwifery Res; 2014 Mar; 19(2):199-202. PubMed ID: 24834091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy.
    Morrow GR
    Cancer Treat Rep; 1984 Sep; 68(9):1177-8. PubMed ID: 6332674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness.
    Muth ER; Jokerst M; Stern RM; Koch KL
    Aviat Space Environ Med; 1995 Nov; 66(11):1041-5. PubMed ID: 8588792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.